The 61% revenue decline and gross loss are severe fundamental deteriorations that overshadow the defense contract win and capital raise. Monitor the 10-Q for detailed cash flow and backlog conversion; the stock is likely to reprice lower on the revenue miss unless the defense pipeline converts rapidly into recognized revenue.
Price Chart
Executive Summary
Laser Photonics reported Q1 2026 results with a sharp 61% YoY revenue decline to $0.9M (from $2.3M), a gross loss of $0.4M versus a $0.9M gross profit a year ago, and a widened net loss of $2.9M. The company highlighted a defense breakthrough with the U.S. Department of War selecting its Laser Shield Anti-Drone System, $9.7M in total capital raised via offerings and warrant inducements, and debt repayment. The revenue collapse and worsening losses are the dominant financial facts, making this filing bearish despite the positive operational milestones.
Key Facts
- Q1 2026 net sales fell to $0.9M from $2.3M YoY, a 61% decline.
- Gross loss of $0.4M vs. gross profit of $0.9M in Q1 2025.
- Net loss widened to $2.9M ($0.11/share) from $1.7M ($0.12/share) YoY.
- Cash balance improved to $1.6M from $0.7M at Dec 31, 2025.
- Raised ~$6.1M in net proceeds during Q1 and ~$3.6M in April 2026 from offerings and warrant inducements.
- All past-due notes payable were repaid during the quarter.
- Laser Shield Anti-Drone System selected by U.S. Department of War under MEIA Vulcan Call for Solutions.
- Entered medical device manufacturing with a $0.25M order from Johnson & Johnson.
- Contract liabilities and deferred revenue rose to ~$4.2M combined at quarter-end.
- Manufacturing consolidation expected to generate nearly $1M in annualized cost savings.
Financial Impact
Revenue declined 61% YoY to $0.9M; gross profit swung to a $0.4M loss; net loss increased $1.2M to $2.9M.
Risk Factors
- Revenue decline may persist if equipment delivery timing does not normalize.
- Gross loss indicates negative unit economics at current scale; cost savings may not fully offset.
- Dependence on warrant inducements and offerings for liquidity; dilution risk remains.
- Defense contracts are early-stage and may not generate near-term revenue.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-028316 |
| Exhibit: ex99-1.htm | 0001493152-26-028316 |
| Document: 0001493152-26-028316-index-headers.html | 0001493152-26-028316 |
| Document: 0001493152-26-028316-index.html | 0001493152-26-028316 |
| Document: 0001493152-26-028316.txt | 0001493152-26-028316 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 3 | $0.6979 | awaiting T+60 | — | $0.6850 (−1.85%) |
Oct 23, 2026 3d ago | 8-K | $0.6968 | awaiting T+60 | — | $0.6850 (+1.69%) |
Oct 20, 2026 7d ago | 8-K | $0.7060 | awaiting T+60 | — | $0.6850 (−2.97%) |
Oct 16, 2026 10d ago | 8-K | $0.6756 | awaiting T+60 | — | $0.6850 (+1.39%) |
Oct 7, 2026 19d ago | 3 | $0.7435 | awaiting T+60 | — | $0.6850 (−7.87%) |
Sep 22, 2026 5w ago | Institutional Cluster | $0.8722 | awaiting T+60 | — | $0.6850 (−21.46%) |
Sep 15, 2026 5w ago | 8-K | $0.8000 | awaiting T+60 | — | $0.6850 (−14.37%) |
Sep 14, 2026 6w ago | 424B4 | $0.7961 | awaiting T+60 | — | $0.6850 (+13.96%) |
Sep 11, 2026 6w ago | EFFECT | $0.6950 | awaiting T+60 | — | $0.6850 (+1.44%) |
Sep 9, 2026 6w ago | S-1/A | $0.7096 | awaiting T+60 | — | $0.6850 (+3.47%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers